FacebookTwitterGoogle+RedditEmail

The Medicare Disaster

During the first weeks of the new Medicare Part D program, the many people who were supposed to benefit–low-income seniors and disabled individuals–were left out in the cold, unable to receive the promised coverage.

Last week in Rhode Island, there were over 2,000 claims, valued at $125,000, where the federal coverage process failed. After pharmacists found “no coverage-rejected” on their computer screens, and people had to pay the full amount with their own funds–or do without–the state stepped in with an emergency order by the governor.

Those whose coverage was rejected got their prescriptions. Now the state must find a way to recoup the money. The same emergency measures were taken in other states. Meanwhile, the Bush administration ordered Medicare drug plan insurers to cover 30-day refills of medications for seniors, with co-pays of no more than $5.

This step was needed to bail out a program that the federal government and the insurance industry had more than two years to plan for. In any other industry, people would have lost their jobs over such a massive failure.

* * *

MEDICARE PART D is now part of the federal health insurance program for seniors over 65 and individuals who are disabled.

Prior to 2006, Medicare consisted of Part A and Part B. Part A covers inpatient hospital care, skilled nursing facilities and hospice care. Part B covers services provided by doctors, outpatient hospital services, home health and other medical and hospital services.

Part D was supposedly created by the 2003 law to offset rising prescription costs and the increase in out-of-pocket spending by recipients. But the most important problem with the plan is that drug costs aren’t covered through the Medicare program.

Instead, recipients have to sign up with private plans offered by insurance companies. As one 82-year-old rightly put it in the Nation magazine, “The purpose of the plan is to bring more customers to the drug company trough, at top-dollar prices.”

A participant in Med D must pay a $250 deductible, and then 25 percent of costs up to $2,250 in total drug costs for a year. That’s $750 in out-of-pocket spending to this point. Then the dreaded “donut hole” kicks in, and there is a $2,850 gap where recipients must pay everything. There is no coverage at all until out-of-pocket expenses reach $3,600.

Medicare Part D covers 95 percent of further expenses. But by this point, seniors living at a poverty-level income will be spending 41 percent of their income on prescription drugs, according to an analysis by Families USA, a health care watchdog group.

Before the New Year, my office was bombarded with phone calls, and colleagues were asked to provide answers to a myriad of questions. “Why should I sign up for this program if I’m healthy now?” was one. I would explain that you have until May 15 to sign up for this “voluntary” program, or else you face a 1 percent compounding penalty for every month you are not signed up (unless you somehow had a private pension coverage which no one coming to us had).

Seniors complained that they shouldn’t face a penalty and couldn’t comprehend why this was a part of the program. I couldn’t either–it seemed like late charges by an overzealous credit card company.

Prior to the launch on January 1, front-line providers were told many things about Medicare Part D, but the people doing the explaining didn’t fully understand the plan, and so neither did the pharmacies. As one senior put it to me, “If CVS, which is dealing with dozens of people daily on this, is confused, how is anyone supposed to know what is going on?”

Because Medicare Part D sends seniors to private insurers, there are more than 40 plans to choose from, with price ranging from $5 to $70 a month depending on the company, the extent of coverage and the state. To learn which plan is the right one for the individual can be a daunting task, especially when over half of all senior citizens haven’t been on the Internet, and people who called drug or insurance companies often got placed on hold and then disconnected after holding for 15 minutes.

After January 1, when seniors went to pharmacies expecting to be covered, tens of thousands discovered that they weren’t. The insurance companies were late in getting people on the list of those who were covered under new plans.

For many seniors and disabled individuals, this meant having to choose between food, paying their rent and purchasing their prescriptions.

One woman whose father had to pay close to $200 for a prescription the other day that he didn’t even use broke down crying because the last few weeks had been so stressful. Her father didn’t speak English, and dealing with Medicare Part D and other state and local pharmaceutical assistance programs was too much.

* * *

IN MY opinion, the people reaping the benefits on this are the pharmaceutical companies, the HMOs, big corporations, members of Congress–all sorts of people other than those the law was supposedly designed for: senior citizens and disabled individuals.

The drug companies are making money in all sorts of ways.

One of the worst aspects of Medicare Part D is that the law directly prohibits negotiating group purchasing agreements and volume discounts with the drug companies. This prohibition will add billions to the drug company profits. Currently, the Veterans Administration and the Department of Defense save over 40 percent because they negotiate wholesale prices for drugs.

Then there are the ways that the plan supports name-brand drugs. Say that Company X makes a medication and sells it for $100–10 times the cost of a generic drug, which would be just as effective for most people. Normally, someone would choose the cheaper generic for $10. This would leave them paying a $2.50 co-payment, and the balance paid by the Medicare drug plan.

But if Company X kicks in the 25 percent co-payment, the more expensive brand name becomes free to the patient–but with Medicare paying a $75 bill. Since it can cost as little as a $1 to make the drug, paying the $25 co-payment is well worth it, since Company X makes a profit of $74.

Drug companies aren’t the only part of Corporate America benefiting. According to the Boston Globe, defense contractor Raytheon will save more than $170 million by using Med D to shift prescription costs previously paid for retirees onto the taxpayers.

The cost to the federal government will be huge. In fact, Richard Foster, Medicare’s chief actuary, apparently lied to Congress about how much Medicare Part D would cost–because he was threatened with firing if he told the truth that the real projections were hundreds of billions more than his agency admitted at the time.

The other day, a woman asked me about signing up for Medicare Part D. She didn’t understand her card or what was sent to her because she had already signed up for the program. It makes me wonder how a homebound individual–with no Internet access, who may or may not be receiving all their mail, who may have mental health issues, and with little or no support system–is supposed to use this program.

I let people know if they complain about this program that it is the result of capitalism, and under socialism, everyone would have universal health care.

CHRIS MURPHY is a social worker in Rhode Island who aids senior citizens and low-income families in accessing federal and state pharmaceutical assistance programs, as well as volunteer opportunities, entitlements and other social service programs. He wrote this frontline report for the Socialist Worker.

 

More articles by:

February 21, 2019
Nick Pemberton
Israel, Venezuela and Nationalism In The Neoliberal Era
Chris Orlet
The Bill and Melinda Gates’ Fair Taxation Scaremongering Tour
Bruce E. Levine
“Heavy Drinking” and the NYT’s Offensive Obit on Herbert Fingarette
Lisi Krall
This Historical Moment Demands Transformation of Our Institutions. The Green New Deal Won’t Do That
Stephanie Savell
Mapping the American War on Terror: Now in 80 Countries
Daniel Warner
New York, New York: a Resounding Victory for New York Over Amazon
Russell Mokhiber
With Monsanto and Glyphosate on the Run AAAS Revokes Award to Scientists Whose Studies Led to Ban on Weedkiller in Sri Lanka and Other Countries
Jesse Jackson
Trump’s Fake National Emergency Moves America Closer to an Autocracy
Alex Campbell
Tracing the Threads in Venezuela: Humanitarian Aid
Jonah Raskin
Mitchel Cohen Takes on Global and Local Goliaths: Profile of a Lifelong Multi-Movement Organizer
Binoy Kampmark
Size Matters: the Demise of the Airbus A380
Elliot Sperber
For Your Children (or: Dead Ahead)
February 20, 2019
Anthony DiMaggio
Withdrawal Pains and Syrian Civil War: An Analysis of U.S. Media Discourse
Charles Pierson
When Saudi Arabia Gets the Bomb
Doug Johnson Hatlem
“Electability” is Real (Unless Married with the Junk Science of Ideological Spectrum Analysis)
Kenneth Surin
The Atlantic Coast Pipeline: Another Boondoggle in Virginia
John Feffer
The Psychology of the Wall
Dean Baker
Modern Monetary Theory and Taxing the Rich
Russell Mokhiber
Citizens Arrested Calling Out Manchin on Rockwool
George Ochenski
Unconstitutional Power Grabs
Michael T. Klare
War With China? It’s Already Under Way
Thomas Knapp
The Real Emergency Isn’t About the Wall, It’s About the Separation of Powers
Manuel García, Jr.
Two Worlds
Daniel Warner
The Martin Ennals and Victorian Prize Winners Contrast with Australia’s Policies against Human Dignity
Norman Solomon
What the Bernie Sanders 2020 Campaign Means for Progressives
Dan Corjescu
2020 Vision: A Strategy of Courage
Matthew Johnson
Why Protest Trump When We Can Impeach Him?
William A. Cohn
Something New and Something Old: a Story Still Being Told
Bill Martin
The Fourth Hypothesis: the Present Juncture of the Trump Clarification and the Watershed Moment on the Washington Mall
February 19, 2019
Richard Falk – Daniel Falcone
Troublesome Possibilities: The Left and Tulsi Gabbard
Patrick Cockburn
She Didn’t Start the Fire: Why Attack the ISIS Bride?
Evaggelos Vallianatos
Literature and Theater During War: Why Euripides Still Matters
Maximilian Werner
The Night of Terror: Wyoming Game and Fish’s Latest Attempt to Close the Book on the Mark Uptain Tragedy
Conn Hallinan
Erdogan is Destined for Another Rebuke in Turkey
Nyla Ali Khan
Politics of Jammu and Kashmir: The Only Viable Way is Forward
Mark Ashwill
On the Outside Looking In: an American in Vietnam
Joyce Nelson
Sir Richard Branson’s Venezuelan-Border PR Stunt
Ron Jacobs
Day of Remembrance and the Music of Anthony Brown        
Cesar Chelala
Women’s Critical Role in Saving the Environment
February 18, 2019
Paul Street
31 Actual National Emergencies
Robert Fisk
What Happened to the Remains of Khashoggi’s Predecessor?
David Mattson
When Grizzly Bears Go Bad: Constructions of Victimhood and Blame
Julian Vigo
USMCA’s Outsourcing of Free Speech to Big Tech
George Wuerthner
How the BLM Serves the West’s Welfare Ranchers
Christopher Fons
The Crimes of Elliot Abrams
FacebookTwitterGoogle+RedditEmail